Associations between sleep duration, sleep disturbance and cardiovascular disease biomarkers among adults in the United States

Abstract Background Sleep problems are associated with abnormal cardiovascular biomarkers and an increased risk of cardiovascular diseases (CVDs). However, studies investigating associations between sleep problems and CVD biomarkers have reported conflicting findings. This study examined the associations between sleep problems and CVD biomarkers in the United States. Methods Data were from the National Health and Nutrition Examination Survey (NHANES) (2007–2018) and analyses were restricted to adults ≥ 20 years ( n = 23,749). CVD biomarkers C-reactive Protein (CRP), low-density lipoproteins, high-density lipoproteins (HDL), triglycerides, insulin, glycosylated hemoglobin (HbA1c), and fasting blood glucose were categorized as abnormal or normal using standardized cut-off points. Sleep problems were assessed by sleep duration (short ≤ 6 h, long ≥ 9 h, and recommended > 6 to < 9 h) and self-reported sleep disturbance (yes, no). Multivariable logistic regression models explored the associations between sleep duration, sleep disturbance, and CVD biomarkers adjusting for sociodemographic characteristics and lifestyle behaviors. Results The mean sleep duration was 7.1 ± 1.5 h and 25.1% of participants reported sleep disturbances. Compared to participants with the recommended sleep duration, those with short sleep duration had higher odds of abnormal levels of HDL (adjusted odds ratio [aOR = 1.20, 95% confidence interval CI = 1.05–1.39), CRP (aOR = 3.08, 95% CI = 1.18–8.05), HbA1c (aOR = 1.25, 95% CI = 1.05–1.49), and insulin (aOR = 1.24, 95% CI = 1.03–1.51). Long sleep duration was associated with increased odds of abnormal CRP (aOR = 6.12, 95% CI = 2.19–17.15), HbA1c (aOR = 1.54, 95% CI = 1.09–2.17), and blood glucose levels (aOR = 1.45, 95% CI = 1.07–1.95). Sleep disturbance predicted abnormal triglyceride (aOR = 1.18, 95% CI = 1.01–1.37) and blood glucose levels (aOR = 1.24, 95% CI = 1.04–1.49). Conclusion Short and long sleep durations were positively associated with abnormal CRP, HDL, HbA1c, blood glucose, and insulin levels, while sleep disturbance was associated with abnormal triglyceride and blood glucose levels. Since sleep is a modifiable factor, adopting healthy sleeping habits may create a balanced metabolism and reduce the risk of developing a CVD. Our study may provide insights into the relationship between sleep duration, sleep disturbance, and CVD risk.